Nils V Montan, incoming president of the INTA, is a pragmatist, and believes that beating pirates requires a carrot as well as a stick. Tabitha Parker asked him about the challenges facing trade mark and copyright owners in the new millennium
The pharmaceutical industry has been given another month to sharpen its arguments as it challenges the South African government over patent rights. But it is also fighting against charities, the media and public opinion. Tabitha Parker reports
Conducting opposition proceedings at OHIM is full of pitfalls for the uninitiated. Tasneem Haq provides 10 rules to help trade mark owners achieve success
In the recent Festo decision, the Federal Circuit unveiled a new approach to analyzing the doctrine of equivalents and the companion doctrine of prosecution history estoppel. In light of this new approach, Allen R Jensen and Stacy D Lewis provide some guidelines for patentees
A long-awaited and far-reaching new Civil Procedure Act came into force in Spain on January 8 2001, which will have a profound effect on all civil proceedings, including IP actions. Gonzalo Ulloa and Ralph Smith reveal the main changes
Australian copyright law has been overhauled with amendments covering moral rights and digital protection. Kristin Stammer provides a guide for copyright owners and users of copyright material
A recent EPO decision has challenged the conventional exclusion on double patenting. Neil Thomson asks where the decision leaves EPO practice, and what impact it will have on proceedings in the UK
Research into the human genome has opened up the possibility of collecting, publishing and even patenting individual genes. Andreas Schrell and Nils Heide explain how a new law will regulate the gene database in Estonia
The past year has seen a greater degree of maturity in the processing of trade mark disputes and predictability in foreseeing their outcome. Jeremy Phillips reviews 10 decisions from across Europe which symbolize the trend
Kathleen E McCarthy, Morgan & Finnegan, LLP
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International